Showing results (191-200 of 330) with videos related to

Sort By:
Pageof 33
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 13, 2019
miRNAs and Long-term Breast Cancer Survival: Evidence from the WHEL StudyLoki Natarajan, Minya Pu, Sherri R Davies, et al.
The Journal of Molecular Diagnostics : JMD|December 21, 2016
An mRNA Gene Expression-Based Signature to Identify FGFR1-Amplified Estrogen Receptor-Positive Breast TumorsJingqin Luo, Shuzhen Liu, Samuel Leung, et al.
Breast Cancer Research and Treatment|September 23, 2019
Research-based PAM50 signature and long-term breast cancer survivalMinya Pu, Karen Messer, Sherri R Davies, et al.
Breast Cancer Research and Treatment|January 17, 2012
Phase II trial of temsirolimus in patients with metastatic breast cancerGini F Fleming, Cynthia X Ma, Dezheng Huo, et al.
Cancer Medicine|September 5, 2015
Associations among ancestry, geography and breast cancer incidence, mortality, and survival in Trinidad and TobagoWayne A Warner, Robert L Morrison, Tammy Y Lee, et al.
Scientific Reports|October 23, 2022
Personalized ctDNA micro-panels can monitor and predict clinical outcomes for patients with triple-negative breast cancerErica K Barnell, Bryan Fisk, Zachary L Skidmore, et al.
Oncotarget|February 23, 2018
ZB716, a steroidal selective estrogen receptor degrader (SERD), is orally efficacious in blocking tumor growth in mouse xenograft modelsShanchun Guo, Changde Zhang, Melyssa Bratton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2015
Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy-Resistant Breast CancerSuzanne E Wardell, Matthew J Ellis, Holly M Alley, et al.
Breast Cancer Research and Treatment|October 22, 2009
Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancerMatthew J Ellis, Li Lin, Robert Crowder, et al.
Molecular Genetics & Genomic Medicine|May 18, 2019
Copy number alterations associated with clinical features in an underrepresented population with breast cancerRaquel M Rodrigues-Peres, Benilton de S Carvalho, Meenakshi Anurag, et al.
Pageof 33